Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Thomaslchim claims to an ONCY director- NOT !

<< Previous

Bullboard Posts

Next >>

Comment by westcoast1000on Jan 29, 2023 3:44pm

177 Views

Post# 35252936

RE:RE:RE:RE:RE:RE:RE:RE:Thomaslchim claims to an ONCY director- NOT !

Noteable,

Thanks for your diligence in uncovering Ichim. Even reading his posts raises suspicions. Directors of companies do not troll for eyeballs or badmouth other posters, if they are serious. His tone is off. His incredulous credentials are the nail in the coffin in terms of evidence of bad behavior.

<< Previous

Bullboard Posts

Next >>

The deep connection between mining and First Nations in Canada